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1. Introduction 
The transferrins are a group of proteins, widely 
distributed in vertebrates, that function in the bind- 
ing and transport of ferric iron. Human serum trans- 
ferrin consists of a single polypeptide chain of mole- 
cular weight 77 000 [ 1, 2] which contains two simi- 
lar binding sites for iron and other metals [3-61. 
Some workers have speculated that transferrin may 
have originated during phylogeny as the result of the 
doubling in size of the structural gene for a smaller 
precursor, which contained a single metal binding site 
(see ref. [7]). 
An investigation of the primary structure of 
human transferrin was initiated in this laboratory to 
evaluate this hypothesis, and to open a path for 
chemical studies of the binding sites of the protein. 
As the polypeptide chain of transferrin is of a large 
size for direct sequence studies, we have cleaved the 
protein with cyanogen bromide to produce seven 
peptide fragments, which have been isolated in high 
yield and characterised with respect to molecular 
weights, amino acid compositions and N-terminal 
groups [8]. The sequences of these fragments are 
being assembled separately and will be used to recon- 
struct the complete amino acid sequence of the origi- 
nal molecule. 
Only one of the CNBr fragments (designated 
CN-6) possesses the same amino terminal residue 
(valine) as the intact transferrin molecule [ 1,9] . This 
26-residue fragment must therefore be derived from 
the amino terminal region of the protein. We report 
here the complete sequence of CN-6, assembled from 
the structure of overlapping tryptic and chymotryptic 
peptides. 
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2. Materials and methods 
2.1. Materials 
Iron-free human serum transferrin was purchased 
from the Sigma Chemical Company Ltd. It was found 
to be substantially homogenous(>95%) by polyacryl- 
amide gel electrophoresis and used without further 
purification. 
The preparation of the S-carboxamidomethyl 
derivative of CN-6 will be described elsewhere [8]. 
Bio-Gel P4 (200-400 mesh) and AG50X4 (30-3.5 
I*) were obtained from Bio-Rad Laboratories and 
carboxymethyl cellulose (CM-52) from Whatman. 
TPCK-treated trypsin was purchased from Worthing- 
ton Biochemical Corporation and chymotrypsin 
(twice recrystallised) and carboxypeptidases A and B 
(DFP treated) from Sigma. 
2.2. Methods 
Procedures used for enzymic digestions, peptide 
separations and acid hydrolysis have been described 
previously [ 10, 1 l] . Amino acid analyses were car- 
ried out with a Bio-cal BC-200 automatic amino acid 
analyzer. In one case a group of peptides were fractionated 
by ion exchange chromatography with a 0.9 X 10 cm 
column of carboxymethyl cellulose at 45°C. The 
column was equilibrated with 25 mM ammonium 
acetate pH 5 .O and the sample dissolved and applied 
in this buffer. Peptides were eluted with a linear gra- 
dient composed of 250 ml each of 25 mM ammonium 
acetate pH 5 .O and 200 mM ammonium acetate pH 
5.0. 
Sequence analysis of peptides was performed by 
the dansyl chloride-Edman degradation procedure as 
described previously [lo]. The position of tryptopha- 
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Table 1 
Amino acid compositions, N-terminal residues and yields of tryptic and chymotryptic peptides from the amino-terminal 
CNBr-fragment of human transferrin 
Peptide Tl T2 T3 T4 T5 Cl c2 c3 CN-6 
CM-cys 
ASP 
Thra 
Sera 
GlU 
pro 
Ala 
Val 
Phe 
Trp 
HiS 
Lys 
Arg 
1.00(l) 0.76 (1) 1.65 (2) 2.0 (2) 
1.00(l) 1.14 (1) 1.23 (1) 1.17(l) 2.0 (2) 
1.10(l) 0.87(l) 0.90 (1) 0.94 (1) 1.8(2) 
1.03(l) 1.15(l) 1.28 (2) 1.7(2) 
1.67 (2) 1.37 (1) 2.90 (3) 3.1(3) 
0.93(l) 0.61(l) 1.1(l) 
2.07 (2) 2.25 (2) 2.0 (2) 
1.23 (1) 1.01(l) 0.77(l) 1.74 (2) 0.85 (1) 2.5 (3) 
0.78(l) 0.95 (1) 
[lib [lib ND 
1.23(l) 0.94 (1) 0.98 (1) 0.75 (1) 1.6(2) 
0.97(l) 1.00(l) 1.04(l) 0.72(l) 1.8(2) 
0.92 (1) 0.77 (1) 0.74 (1) 0.94 (1) 1.9(2) 
N-terminal Val Thr Trp Ser Asp Val 
Yield (%) 31 4 4 5 10 10 
Figures in parentheses after the molar ratios represent the assumed number of residues. 
Ala 
6 
Arg 
4 
Val 
a Not corrected for partial destruction. 
b From ammo acid sequence. 
nyl residues, which are not determined by this proce- 
dure, were inferred from the loss of absorption at 280 
nm by the peptide after the appropriate Edman de- 
gradation step, or when in a C-terminal position in a 
peptide, identified as the dansyl derivative by omit- 
ting acid hydrolysis. 
The amide contents of peptides were deduced 
from their electrophoretic mobilities at pH 6.5 [ 121 
or by total enzymic digestion with aminopeptidase 
M [lo]. 
3. Results and discussion 
The amino acid compositions and N-terminal resi- 
dues of CN-6 and the peptides obtained from it by 
digestion with trypsin or chymotrypsin are given in 
table 1. Sequence analysis of these peptides has per- 
mitted the deduction of a complete and unambiguous 
sequence for CN-6 as shown in fig. 1. 
The amino terminal position of Tl and Cl is clearly 
indicated by their possession of N-terminal valine. T5, 
the only tryptic peptide devoid of lysine and arginine, 
must occupy the C-terminal position in the fragment. 
From the electrophoretic mobilities of peptides 
the only incomplete amide assignment was with pep- 
tide T3, where a residue each of glutamic acid and 
glutamine were found to be present. An aliquot of 
this peptide was subsequently subjected to five Ed- 
man degradation cycles and then subjected to amino 
acid analysis after incomplete hydrolysis with amino- 
peptidase M. The following composition was obtained: 
Thre .7 7, Ser+Glne .27 Glur .e Ala,, .6 9 His 0.2 3 
LYS~.~ s. Residue 12 is therefore identified as gluta- 
mine and residue 14 as glutamic acid. 
It is interesting to note that in a separate investiga- 
tion of the cyanogen bromide fragments of human 
transferrin, Bezkorovainy and Grohlich [ 131 ob- 
tained a fragment similar to CN-6, which they desig- 
nate C-l-b. The fragment has an N-terminal residue of 
valine, but shows in hydrolysates the presence of 
leucine and tyrosine, and must therefore be judged to 
be a slightly impure form of CN-6. No sequence stud- 
ies of the fragment have been reported. 
Comparison of the sequence of CN-6 with the 
reported N-terminal sequences of other serum pro- 
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-A_.A.-.L_.2.A~~A~~~A~_AA 
< , i > < , 
Tl T2 T3 
___.&>_ 
Val-Pro-Asp-Lys-Thr-Val-Arg-Trp-Ala-Val-SerGlnHis-G1r-Cys~Lys~ 
_ _ . 
> < , 
c3 
_ _ _ _ 12 
< > 
T4 T5 
Se-Glu-Cy-Phe-Arg-Asp-His-Homoserine Iactone 
Fig. 1. The amino acid sequence of the amino-terminal fragment derived from sequence analysis of overlapping tryptic (T) and 
chymotryptic (C) peptides; ‘indicates a sequence determined by the dansyl-Edman procedure; + indicates a sequence derived 
from a time-course carboxypeptidase digest. 
teins shows a slight similarity with the sequences of 
haptoglobin 1 cr chain [ 141 and (or -glycoprotein [ 151 
which are both homologous with the immunoglobulin 
group. Clearly more extensive sequence studies are 
required to evaluate the possibility of distant homo- 
logy between transferrin and this group. Such studies 
are currently in progress. 
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